Pharmacological inhibition on the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; also referred to as FRAP-similar protein (FRP1)) has emerged for a promising method for most cancers therapy that exploits artificial lethal interactions with proteins involved in DNA injury repair, overcomes resistance to other therapies and improves antitumour immunity. https://salmeterol66543.develop-blog.com/32678729/mertansine-options